UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SK Chemicals to spin off vaccine biz
SK Chemicals said it would spin off its vaccine business, establish it as a...
by So Jae-hyeon
|
2018-02-26 14:34
라인
How will Kolmar raise W1.3 trillion to buy CJ HealthCare?
Kolmar Korea is expected to transform into a pharmaceutical giant with annu...
by So Jae-hyeon
|
2018-02-23 16:21
라인
Kolmar Korea ups capacity through CJ HealthCare buyout
Kolmar Korea is to become a formidable player in the pharmaceutical industr...
by So Jae-hyeon
|
2018-02-21 15:58
라인
Kolmar Korea is preferred bidder for CJ HealthCare
Kolmar Korea is one step nearer to win the bidding war to acquire CJ Health...
by So Jae-hyeon
|
2018-02-20 15:41
라인
Handok sales continued to decline in Q4
Handok is so desperate to stop the continued sales decline that the drugmak...
by So Jae-hyeon
|
2018-02-19 15:51
라인
‘Highest bid for CJ HealthCare reaches ₩1.4 trillion’
The bidding war to acquire CJ HealthCare is heating up, with the highest bi...
by So Jae-hyeon
|
2018-02-19 15:28
라인
Hanmi’s botched trials drag down pharmaceutical shares
Hanmi Pharmaceutical’s botched clinical trials on a new drug under a licens...
by So Jae-hyeon
|
2018-02-19 11:53
라인
Medytox in final stage to sell facial filler in China
Medytox’ entry into the Chinese anti-wrinkle injections market with its sel...
by So Jae-hyeon
|
2018-02-14 11:37
라인
4 drugmakers, biotech firms to list on KOSDAQ in February
The listing of pharmaceutical and biotech companies on the KOSDAQ market wi...
by So Jae-hyeon
|
2018-02-12 14:19
라인
Dementia treatments in active R&D with government support
With the government promising to spend 1 trillion won ($920 million) budget...
by So Jae-hyeon
|
2018-02-08 16:10
라인
Seoul to spend ₩1 trillion on dementia
The government said it would spend 1 trillion won ($920 million) on researc...
by So Jae-hyeon
|
2018-02-06 16:26
라인
AstraZeneca to get new local partner for antidiabetic sale
AstraZeneca Korea will likely seek a new local sales partner for its antidi...
by So Jae-hyeon
|
2018-02-05 11:30
라인
Korean biosimilars expand global presence
Korean biosimilar drugs have begun to expand their presence in the global m...
by So Jae-hyeon
|
2018-01-31 11:51
라인
FedEx sees opportunities in healthcare business
Package delivery companies are essential players in the healthcare industry...
by So Jae-hyeon
|
2018-01-30 14:47
라인
Patent expirations to open way for generic drugs in 2018
As well-selling original drugs, including Gilead’s hepatitis B treatment Vi...
by So Jae-hyeon
|
2018-01-25 15:38
라인
MSD slows down in hyperlipidemia combos market
MSD’s performance is slowing down in the local market of ezetimibe-active c...
by So Jae-hyeon
|
2018-01-23 16:03
라인
Hanmi, Chong Kun Dang lead Viagra copies market
The polarization among local drugmakers is intensifying in the erectile dys...
by So Jae-hyeon
|
2018-01-22 14:44
라인
New local prescription drugs performed well in 2017
Novel drugs developed by domestic pharmaceutical companies achieved substan...
by So Jae-hyeon
|
2018-01-19 13:46
라인
Pfizer Korea recorded most drug recalls in 2017
Pfizer Korea recorded the largest number of drug recalls and disposals amon...
by So Jae-hyeon
|
2018-01-17 13:36
라인
Competition heats up in hair loss treatment market
Local drugmakers are increasingly competing to sell over-the-counter (OTC) ...
by So Jae-hyeon
|
2018-01-15 15:02
-
1
2
3
4
5
6
7
8
9
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top